Patents Represented by Attorney, Agent or Law Firm Bristol-Myers Squibbs Co.
  • Patent number: 7387427
    Abstract: The invention relates to a conical screw blender which comprises an inverted cone-shaped vessel. The blender also includes a material inlet, a material outlet, a driven screw housed within the vessel, and at least two non-diffuse gas injection lines attached to the vessel. The conical screw blender of the present invention can be used not only for the mixing of materials, but also for the drying of materials.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: June 17, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Win-Chin Chiang, Nagendra Rangavajla
  • Patent number: 7303745
    Abstract: The present invention is directed to a novel method for preventing or treating the development of respiratory allergies. The method comprises prenatal and/or postnatal administration of a therapeutically effective amount of LGG.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: December 4, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Udo Herz, Harald Renz, Nicole Bluemer, Holger Garn
  • Patent number: 6632812
    Abstract: This invention relates to novel lactams of Formula (I): having drug and bio-affecting properties, their pharmaceutical compositions and methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of A&bgr;-peptide, thereby acting to prevent the formation of neurological deposits of amyloid protein. More particularly, the present invention relates to the treatment of neurological disorders related to &bgr;-amyloid production such as Alzheimer's disease and Down's Syndrome.
    Type: Grant
    Filed: April 11, 2001
    Date of Patent: October 14, 2003
    Assignee: Dupont Pharmaceuticals Company
    Inventors: Qi Han, Hong Liu, Richard E. Olson, Michael G. Yang
  • Patent number: 5622929
    Abstract: Provided are drug/ligand compounds of Formula (I): ##STR1## in which D is a drug moiety;n is an integer from 1 to 10;p is an integer from 1 to 6;Y is O or NH.sub.2.sup.+ C1.sup.- ;z is 0 or 1;q is about 1 to about 10;X is a ligand; and,A is a Michael Addition Adduct.In a preferred embodiment, the ligand is an immunoglobulin, preferably a chimeric antibody or fragment thereof. Also provided are formulations comprising as an active ingredient a compound of Formula (I), intermediates useful for preparing the compounds of Formula (I), processes for preparing the compounds of Formula (I), and methods for using the compounds of the invention.
    Type: Grant
    Filed: January 23, 1992
    Date of Patent: April 22, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: David Willner, Pamela A. Trail, H. Dalton King, Sandra J. Hofstead, Robert S. Greenfield, Gary R. Braslawsky